This HBW Insight-led webinar brings together Jefferies’ David Hayes and CHPA’s Scott Melville, with HBW Insight journalists David Ridley and Malcolm Spicer, to ask a blunt question: With two disappointing cough and cold seasons behind the industry, have OTC manufacturers built a structurally fragile growth model?
As consumers grow more interested in self-care and prevention, the panel will examine whether the consumer health industry is moving fast enough to meet that demand — and what regulatory change is needed to let companies bring genuinely new products to market.
David Hayes
Managing Director
View profile
Managing Director
Equity Research Jefferies
David Hayes joined Jefferies in October 2023 to cover the European food and home & personal care sectors. He has 20+ years of experience covering the staples sector, having previously held senior positions at Societe Generale and Bank of America Merrill Lynch.
David Hayes joined Jefferies in October 2023 to cover the European food and home & personal care sectors. He has 20+ years of experience covering the staples sector, having previously held senior positions at Societe Generale and Bank of America Merrill Lynch.
Scott Melville
President & CEO
View profile
President & CEO
Consumer Healthcare Products Association (CHPA)
Scott Melville leads the Consumer Healthcare Products Association’s efforts to empower consumer self-care by preserving and expanding choice and availability of consumer healthcare products, including OTC medicines, dietary supplements and OTC medical devices.
Scott Melville leads the Consumer Healthcare Products Association’s efforts to empower consumer self-care by preserving and expanding choice and availability of consumer healthcare products, including OTC medicines, dietary supplements and OTC medical devices.
Prior to joining CHPA, Melville served as senior vice president of government affairs and general counsel for the Healthcare Distribution Alliance (formerly HDMA), representing pharmaceutical wholesale distributors.
David Ridley
Senior Editor
View profile
Senior Editor
HBW Insight
David Ridley is a consumer health analyst covering OTC markets, self-care trends, and industry strategy for HBW Insight. His work focuses on how shifts in consumer behaviour, regulation, and innovation are shaping the future of consumer healthcare.
David Ridley is a consumer health analyst covering OTC markets, self-care trends, and industry strategy for HBW Insight. His work focuses on how shifts in consumer behaviour, regulation, and innovation are shaping the future of consumer healthcare.
Malcolm Spicer
US Consumer Health Managing Editor
View profile
US Consumer Health Managing Editor
HBW Insight
Malcolm has expertly covered the OTC drug and nutritional supplement industries and markets since 2006. He provides authoritative and analytical insight into how and why the US Food and Drug Administration regulates OTC drugs. Malcolm focuses on how companies competing in the consumer health industry can most efficiently and effectively comply with FDA regulations.
Malcolm has expertly covered the OTC drug and nutritional supplement industries and markets since 2006. He provides authoritative and analytical insight into how and why the US Food and Drug Administration regulates OTC drugs. Malcolm focuses on how companies competing in the consumer health industry can most efficiently and effectively comply with FDA regulations.
Lucie Ellis-Taitt
Editor-in-Chief
View profile
Editor-in-Chief
HBW Insight | In Vivo | Medtech Insight | Generics Bulletin
Covering the biopharma space since 2012, Lucie writes feature articles on the topics of leadership, R&D, innovation and more. She also regularly attends industry events and moderates panel discussions on topics such as investment trends, women’s health and R&D hot topics. This year, Lucie took on the role of editor-in-chief for HBW Insight, In Vivo, Medtech Insight and Generics Bulletin.
Covering the biopharma space since 2012, Lucie writes feature articles on the topics of leadership, R&D, innovation and more. She also regularly attends industry events and moderates panel discussions on topics such as investment trends, women’s health and R&D hot topics. This year, Lucie took on the role of editor-in-chief for HBW Insight, In Vivo, Medtech Insight and Generics Bulletin.
